{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:51:44Z","timestamp":1775544704639,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00108-026-02069-6","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:53:40Z","timestamp":1773053620000},"page":"22-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pr\u00e4vention der rheumatoiden Arthritis","Prevention of rheumatoid arthritis"],"prefix":"10.1007","volume":"67","author":[{"given":"Ulf","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2069_CR1","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha\u00a0D, Smolen\u00a0JS (2018) Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA 320:1360\u20131372","journal-title":"JAMA"},{"key":"2069_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","volume":"400","author":"DI Krijbolder","year":"2022","unstructured":"Krijbolder\u00a0DI, Verstappen\u00a0M, van Dijk\u00a0BT et\u00a0al (2022) Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet 400:283\u2013294","journal-title":"Lancet"},{"key":"2069_CR3","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1016\/S2665-9913(24)00196-6","volume":"6","author":"GA Dumoulin","year":"2024","unstructured":"Dumoulin\u00a0GA, Krijbolder\u00a0DI, Visser\u00a0K et\u00a0al (2024) Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4\u2011year data from the TREAT EARLIER trial. Lancet Rheumatol 6:e827\u2013e836","journal-title":"Lancet Rheumatol"},{"key":"2069_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","volume":"403","author":"AP Cope","year":"2024","unstructured":"Cope\u00a0AP, Jasenecova\u00a0M, Vasconcelos\u00a0JC et\u00a0al (2024) Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial. Lancet 403:838\u2013849","journal-title":"Lancet"},{"key":"2069_CR5","unstructured":"Cope A (2025) ALTO study presented at EULAR 2025, Barcelona. Abstract OP0004"},{"key":"2069_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","volume":"403","author":"J Rech","year":"2024","unstructured":"Rech\u00a0J, Tascilar\u00a0K, Hagen\u00a0M et\u00a0al (2024) Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet 403:850\u2013859","journal-title":"Lancet"},{"key":"2069_CR7","first-page":"111","volume":"84","author":"E van Mulligen","year":"2023","unstructured":"van Mulligen\u00a0E, Bour\u00a0S, Goossens\u00a0LMA et\u00a0al (2023) Is a 1\u2011year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial. Ann Rheum Dis 84:111\u2013118","journal-title":"Ann Rheum Dis"},{"key":"2069_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","volume":"76","author":"HW van Steenbergen","year":"2017","unstructured":"van Steenbergen\u00a0HW, Aletaha\u00a0D, Beaart-van de Voorde\u00a0LJ et\u00a0al (2017) EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis 76:491\u2013496","journal-title":"Ann Rheum Dis"},{"key":"2069_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/ard-2023-224211","volume":"84","author":"KD Deane","year":"2025","unstructured":"Deane\u00a0KD, Holers\u00a0VM, Emery\u00a0P et\u00a0al (2025) Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease. Ann Rheum Dis 84:14\u201328","journal-title":"Ann Rheum Dis"},{"key":"2069_CR10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41584-023-01035-y","volume":"19","author":"HW Steenbergen","year":"2023","unstructured":"Steenbergen\u00a0HW, Gierisch\u00a0MJ, Cope\u00a0AP (2023) Prevention trials for rheumatoid arthritis: where do we stand? Nat Rev Rheumatol 19:767\u2013777","journal-title":"Nat Rev Rheumatol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02069-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:57:55Z","timestamp":1775541475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02069-6"}},"subtitle":["Aktuelle Studienergebnisse zur therapeutischen Intervention bei Risikopatienten","Current study results on the therapeutic intervention in patients at risk"],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":10,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2069"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02069-6","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"6 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Wagner gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}